Search research articles
Contact Us
Filters
Showing results (261-270 of 541) with videos related to
Page
of 55
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
July 12, 2001
Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism
T Wada, S H Schurman, M Otsu, et al.
Laboratory Animal Science
|
October 1, 1985
Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques: epidemiologic studies
C C Tsai, W E Giddens, W R Morton, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 1, 1994
Chronic in vivo evaluation of an electrohydraulic total artificial heart
S M Parnis, L S Yu, B D Ochs, et al.
Veterinary Immunology and Immunopathology
|
October 3, 1999
Bone marrow transplantation for canine X-linked severe combined immunodeficiency
B J Hartnett, P S Henthorn, P F Moore, et al.
The Journal of Infectious Diseases
|
October 1, 1987
Self-infusion of intravenous immunoglobulin by immunodeficient patients at home
H D Ochs, M L Lee, S H Fischer, et al.
Blood
|
September 10, 1998
Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets
A Oda, H D Ochs, B J Druker, et al.
The Journal of Experimental Medicine
|
June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance
Maxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
The American Journal of Pathology
|
May 1, 1985
Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques. Pathologic observations and transmission studies
W E Giddens, C C Tsai, W R Morton, et al.
The Journal of Allergy and Clinical Immunology
|
September 8, 2020
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
Hans-Hartmut Peter, Hans D Ochs, Charlotte Cunningham-Rundles, et al.
Journal of Clinical Immunology
|
June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
Mark Ballow, Paul J Pinciaro, Timothy Craig, et al.
Page
of 55
Search research articles
Search
Showing results (261-270 of 541) with videos related to
Sort By:
Page
of 55
Proceedings of the National Academy of Sciences of the United States of America
|
July 12, 2001
Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism
T Wada, S H Schurman, M Otsu, et al.
Laboratory Animal Science
|
October 1, 1985
Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques: epidemiologic studies
C C Tsai, W E Giddens, W R Morton, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 1, 1994
Chronic in vivo evaluation of an electrohydraulic total artificial heart
S M Parnis, L S Yu, B D Ochs, et al.
Veterinary Immunology and Immunopathology
|
October 3, 1999
Bone marrow transplantation for canine X-linked severe combined immunodeficiency
B J Hartnett, P S Henthorn, P F Moore, et al.
The Journal of Infectious Diseases
|
October 1, 1987
Self-infusion of intravenous immunoglobulin by immunodeficient patients at home
H D Ochs, M L Lee, S H Fischer, et al.
Blood
|
September 10, 1998
Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets
A Oda, H D Ochs, B J Druker, et al.
The Journal of Experimental Medicine
|
June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance
Maxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
The American Journal of Pathology
|
May 1, 1985
Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques. Pathologic observations and transmission studies
W E Giddens, C C Tsai, W R Morton, et al.
The Journal of Allergy and Clinical Immunology
|
September 8, 2020
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
Hans-Hartmut Peter, Hans D Ochs, Charlotte Cunningham-Rundles, et al.
Journal of Clinical Immunology
|
June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
Mark Ballow, Paul J Pinciaro, Timothy Craig, et al.
Page
of 55